Telesis Bio, Inc. (NASDAQ:TBIO) Sees Significant Growth in Short Interest
Telesis Bio, Inc. (NASDAQ:TBIO – Get Free Report) was the target of a significant increase in short interest during the month of September. As of September 15th, there was short interest totalling 29,700 shares, an increase of 141.5% from the August 31st total of 12,300 shares. Approximately 5.7% of the shares of the stock are […]
More Stories
CAE (NYSE:CAE) Upgraded at Desjardins
Desjardins upgraded shares of CAE (NYSE:CAE – Free Report) (TSE:CAE) from a hold rating to a buy rating in a...
Enfusion (NYSE:ENFN) Stock Price Expected to Rise, Piper Sandler Analyst Says
Enfusion (NYSE:ENFN – Free Report) had its price objective lifted by Piper Sandler from $10.00 to $11.50 in a research...
Research Analysts Set Expectations for WGO Q3 Earnings
Winnebago Industries, Inc. (NYSE:WGO – Free Report) – Research analysts at Roth Capital boosted their Q3 2025 earnings per share...
CVD Equipment (NASDAQ:CVV) Now Covered by StockNews.com
StockNews.com began coverage on shares of CVD Equipment (NASDAQ:CVV – Free Report) in a research report released on Monday. The...
Barclays Cuts Revance Therapeutics (NASDAQ:RVNC) Price Target to $3.00
Revance Therapeutics (NASDAQ:RVNC – Free Report) had its price target trimmed by Barclays from $7.00 to $3.00 in a research...
HashiCorp (NASDAQ:HCP) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of HashiCorp (NASDAQ:HCP – Free Report) in a report released on Monday morning. The firm...